Literature DB >> 12808164

Role of insulin and the IGF system in renal hypertrophy in diabetic Psammomys obesus (sand rat).

Itamar Raz1, Isaiah Wexler, Ofra Weiss, Allan Flyvbjerg, Yael Segev, Ariella Rauchwerger, Gadi Raz, Mogher Khamaisi.   

Abstract

BACKGROUND: Diabetic nephropathy is caused by multiple factors related to the altered metabolic environment in diabetes mellitus (DM). Experimental diabetic kidney disease is characterized by renal hypertrophy associated with increased tissue concentrations of insulin-like growth factor I (IGF-I). To assess the specific roles of serum insulin and glucose in mediating the development of diabetic nephropathy, the effects of both hyperinsulinaemic and hypoinsulinaemic DM were studied in Psammomys obesus (sand rat), a model of type 2 DM.
METHODS: The IGF-I system was studied in normal Psammomys obesus gerbils and at 5, 15 and 70 days after the induction of either hyper- or hypoinsulinaemic DM. To induce hyperinsulinaemic DM, Psammomys were raised on a high-energy diet. Hypoinsulinaemic DM was induced by either administration of streptozotocin or a specially designed diet.
RESULTS: Hyperinsulinaemic hyperglycaemic Psammomys did not exhibit renal hypertrophy (unchanged kidney/body-weight ratio) and renal IGF-I levels were in the normal range on days 5, 15 and 70. In contrast, Psammomys with hypoinsulinaemic hyperglycaemia induced either by streptozotocin injection or by pancreas exhaustion brought on by a long-term caloric excess diet, had significant increases in kidney/body-weight ratio which were associated with elevated renal IGF-I and mRNA and protein levels of kidney IGF binding protein I.
CONCLUSIONS: This study shows that serum insulin levels in the presence of hyperglycaemia have an important role in the development of experimental diabetic nephropathy in the Psammomys model. The implication of this finding is that the pathophysiological mechanisms for diabetic kidney disease in experimental models may be different for type 1 and type 2 DM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808164     DOI: 10.1093/ndt/gfg170

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.

Authors:  Tetyana L Vasylyeva; Robert J Ferry
Journal:  Diabetes Res Clin Pract       Date:  2006-10-02       Impact factor: 5.602

2.  The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.

Authors:  Ariel Troib; Daniel Landau; Jack F Youngren; Leonid Kachko; Ralph Rabkin; Yael Segev
Journal:  Growth Horm IGF Res       Date:  2011-08-23       Impact factor: 2.372

Review 3.  Modelling diabetic nephropathy in mice.

Authors:  Kengo Azushima; Susan B Gurley; Thomas M Coffman
Journal:  Nat Rev Nephrol       Date:  2017-10-24       Impact factor: 28.314

4.  Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3beta?

Authors:  Rosemarie M Carew; Marianna Sadagurski; Roel Goldschmeding; Finian Martin; Morris F White; Derek P Brazil
Journal:  BMC Dev Biol       Date:  2010-07-06       Impact factor: 1.978

5.  Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.

Authors:  Sung-Hsun Yu; Navneet Kumar Dubey; Wei-Shan Li; Ming-Che Liu; Han-Sun Chiang; Sy-Jye Leu; Ying-Hua Shieh; Feng-Chou Tsai; Win-Ping Deng
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

6.  Electroretinographic evidence suggesting that the type 2 diabetic retinopathy of the sand rat Psammomys obesus is comparable to that of humans.

Authors:  Ahmed Dellaa; Maha Benlarbi; Imane Hammoum; Nouha Gammoudi; Mohamed Dogui; Riadh Messaoud; Rached Azaiz; Ridha Charfeddine; Moncef Khairallah; Pierre Lachapelle; Rafika Ben Chaouacha-Chekir
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.